Women’s health conditions have spent decades at the margins of cannabis research, clinical care, and state policy. As evidence grows and more programs begin considering conditions such as endometriosis, orgasmic disorder, uterine fibroids, and ovarian cysts, this panel looks beyond recognition to what comes next. What research is still needed? How can advocates turn emerging evidence into policy change? And what will it take to build a medical cannabis system that responds to women’s health before another generation is left waiting?